Haleon plc (FRA:H6D0)
Germany · Delayed Price · Currency is EUR | Market Cap | 38.04B +0.8% |
| Revenue (ttm) | 12.95B +1.2% |
| Net Income | 1.88B +6.6% |
| EPS | 0.21 +8.5% |
| Shares Out | n/a |
| PE Ratio | 20.18 |
| Forward PE | 16.87 |
| Dividend | 0.08 (1.98%) |
| Ex-Dividend Date | Aug 13, 2026 |
| Volume | n/a |
| Open | 4.340 |
| Previous Close | 4.261 |
| Day's Range | 4.325 - 4.344 |
| 52-Week Range | 3.659 - 4.743 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 30, 2026 |
About Haleon
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal dr... [Read more]
Financial Performance
In 2025, Haleon's revenue was 11.03 billion, a decrease of -1.81% compared to the previous year's 11.23 billion. Earnings were 1.67 billion, an increase of 15.60%.
Financial numbers in GBP Financial StatementsNews
Haleon plc: Announces Pricing Terms, Expiration and Results of its Cash Tender Offer for outstanding 2027 Notes
LONDON, Aug. 19, 2026 /PRNewswire/ -- Haleon plc (the "Company" or "Haleon") (LSE/NYSE: HLN) today announces the pricing terms, expiration and results of the offer to buy back any and all of the outst...
Haleon plc: Cash tender offer for outstanding 2027 3.375% Fixed Rate Notes
LONDON, Aug. 11, 2026 /PRNewswire/ -- Haleon plc (the "Company" or "Haleon") (LSE/NYSE: HLN) today announces that its wholly owned subsidiary, Haleon US Capital LLC (the "Offeror") is offering to buy ...
Drugmakers, retailers must face 'maximum strength' claim in decongestant false ad litigation in US
A federal appeals court on Thursday revived portions of nationwide litigation in which consumers accused drugmakers such as Procter & Gamble and retailers such as CVS of selling billions of dollars o...
Haleon Earnings Call Transcript: H1 2026
Q2 organic sales grew 3.1% with margin and EPS improvements, led by North America, China, and Latin America. Outlook remains confident for 3%-5% full-year growth, with H2 expected to benefit from emerging markets, cold and flu recovery, and continued innovation.
Haleon Quarterly report: H1 2026
Haleon has published its H1 2026 quarterly earnings report on July 30, 2026.
Haleon Slides: H1 2026
Haleon has posted slides in relation to its H1 2026 quarterly earnings report, which was published on July 30, 2026.
Sensodyne maker Haleon posts higher second-quarter organic revenue growth
British consumer health company Haleon reported second-quarter organic sales growth of 3.1% on Thursday, in line with market expectations, driven by strong demand for its oral health produc...
From shampoo to cookies, consumer products get an AI makeover
French cosmetics company L'Oreal has used AI to identify molecules in its skincare products that can be repurposed for use in shampoo and can now create products four times faster than before, a seni...
Haleon to Accelerate AI-powered Transformation With New Five-year Microsoft Collaboration
LONDON--(BUSINESS WIRE)-- #AI--Haleon, a consumer health company solely focused on better everyday health, today announces a new five-year collaboration with Microsoft to scale digital, data and AI ca...
Haleon Invests in India to Deliver Better Everyday Health to Rural Communities
LONDON--(BUSINESS WIRE)-- #AI--Haleon, a consumer company that is solely focused on better everyday health, today announces plans to expand its business in India, one of its fastest-growing markets an...
Haleon to Invest $233.5 Million in India Plant Amid Push Into Emerging Markets
The facility to make oral-health products in Madhya Pradesh is the largest plant the company has taken on.
Haleon Issues Voluntary Nationwide Recall of Gas-X Extra Strength Softgels 125mg, 120 ct. and 72 ct.
WARREN, N.J.--(BUSINESS WIRE)--Haleon (NYSE: HLN) is voluntarily recalling four lots of Gas-X Extra Strength Softgels 125mg, 120 ct. and 72 ct. distributed on or about April 13, 2026 to the consumer l...
Haleon Transcript: 23rd annual dbAccess Global Consumer Conference
Strategic focus is on growth, productivity, and culture, with major investments in emerging markets and digital channels. Cost savings and operational efficiencies are driving margin improvements, while innovation and targeted M&A aim to shift the portfolio toward higher-growth, daily-use health categories.
TUMS Kicks Off the "TUMS Food Match Cup," a Celebration of Global Soccer Fandom and Food Love Through Bold Flavor Mashups
New campaign features global-inspired recipes, a multi-city food truck tour, creator collaborations, a sweepstakes and more, inspired by the summer's biggest soccer tournament WARREN, N.J., June 3, 20...
‘For The Assist': Haleon Canada launches national campaign with Canada Soccer to celebrate the small health supports behind Canadian wellbeing
New Haleon Canada creative featuring Richie Laryea anchors integrated campaign spanning media, retail, and cross-country experiential New Haleon Canada creative featuring Richie Laryea anchors integra...
Centrum Launches Newly Reformulated Adults 50+ Complete Multivitamin with Clinically Shown Cognitive Benefits
New science-backed daily multivitamin specially formulated with essential vitamins and minerals to meet nutritional and health needs of older adults New science-backed daily multivitamin specially for...
Haleon Earnings Call Transcript: Q1 2026
Q1 organic revenue grew 2.2%, led by strong oral health and innovation, despite weak cold and flu and macro uncertainty. Guidance for 3%-5% organic revenue growth and high single-digit operating profit is maintained, with growth expected to accelerate in North America, China, and LATAM.
Haleon Earnings release: Q1 2026
Haleon released its Q1 2026 earnings on April 29, 2026, summarizing the period's financial results.
Haleon Slides: Q1 2026
Haleon has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 29, 2026.
Sensodyne maker Haleon reports organic revenue growth sligtly below estimates
British consumer healthcare group Haleon on Wednesday reported first quarter revenue growth slightly below analyst expectations, as weakness in other international markets offset growth in Nort...
Haleon Launches For the Assist Campaign in Partnership with the U.S. Soccer Federation Featuring Stars Tyler Adams and Crystal Dunn
WARREN, N.J.--(BUSINESS WIRE)--Today, Haleon, the consumer company that is solely focused on better everyday health, in partnership with the U.S. Soccer Federation, launched For the Assist, a new nati...
Haleon Appoints Richard Manso as US Chief Marketing Officer to Advance Data-driven, Consumer-centric Marketing in Delivering Better Everyday Health
WARREN, N.J.--(BUSINESS WIRE)--Today Haleon (NYSE: HLN), the consumer company that is solely focused on better everyday health, announced the appointment of Richard Manso as US Chief Marketing Officer...
NEW parodontax Gum Strengthen & Protect Launches as a Daily Solution for Long-Term Gum Protection
WARREN, N.J.--(BUSINESS WIRE)--parodontax, the gum expert brand from Haleon, has launched NEW parodontax Gum Strengthen & Protect Toothpaste and Mouthwash with Hyaluronic Acid^, a daily oral care inno...
Haleon Strengthens Commitment to China as Consumers Focus on Better Everyday Health
SHANGHAI--(BUSINESS WIRE)-- #ConsumerHealth--Haleon, a consumer company that is solely focused on better everyday health, is investing £65 million in a new state-of-the-art oral health manufacturing s...
Haleon makes oral-health push in China as other Western brands falter
Haleon is stepping up its Chinese expansion, pushing into second- and third-tier cities and tailoring its gum-health products to local tastes, aiming to succeed where many Western consumer brands hav...